English

Medigus Ltd.

EDGAR

MDGS Report (type unavailable) · filed 2025-08-22

Annual consolidated revenue for 2024: about USD 29.86M, using the latest reported figures. The previous period, 2023, was about USD 91.72M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

54 thousand USD

2018 Q2 · USD

Exact inputs and evidence

Revenue: 54000 USD Source

Operating margin

-2,074.07%

2018 Q2 · %

Exact inputs and evidence

Operating Income: -1120000 USD Source
Revenue: 54000 USD Source

Operating cash flow

-962 thousand USD

2018 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -962000 USD Source

Cash and cash equivalents: 8.75 million USD 2024-12-31 Source
Exact value

8753000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-08-22.

Financial data available through: 2024-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2024-12-31
Operating income: 10 of 11 periods available· newest 2024-12-31
Net income: 8 of 11 periods available· newest 2024-12-31
Operating cash flow: 10 of 11 periods available· newest 2024-12-31
Capital expenditure: 10 of 11 periods available· newest 2024-12-31
Total assets: 9 of 11 periods available· newest 2024-12-31
Total liabilities: 9 of 11 periods available· newest 2024-12-31
Current assets: 9 of 11 periods available· newest 2024-12-31
Current liabilities: 9 of 11 periods available· newest 2024-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2024-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-67.4%

Prior period

USD 91.72 million

2023-01-01 – 2023-12-31
Current period

USD 29.86 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

29858000 − 91724000 = -61866000 USD

91724000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
29858000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Medigus Ltd. · 2024-12-31 Medigus Ltd. (edgar:1618500) Year-over-year change in Revenue: -61866000 USD Concept: fundies:Revenue Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 29858000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#2718589 Filing: 000121390025037618 Input fundies:Revenue: 91724000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#2719003 Filing: 000121390025037618
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 10 million

Prior period

−USD 16.03 million

2023-01-01 – 2023-12-31
Current period

−USD 6.03 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-6027000 − -16025000 = 9998000 USD

-16025000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-6027000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Medigus Ltd. · 2024-12-31 Medigus Ltd. (edgar:1618500) Year-over-year change in Net income: 9998000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -6027000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1089392 Filing: 000121390025037618 Input fundies:NetIncome: -16025000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1089724 Filing: 000121390025037618
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 4.42 million

Prior period

−USD 6.25 million

2023-01-01 – 2023-12-31
Current period

−USD 1.82 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-1824000 − -6247000 = 4423000 USD

-6247000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-1824000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Medigus Ltd. · 2024-12-31 Medigus Ltd. (edgar:1618500) Year-over-year change in Operating cash flow: 4423000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1824000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1318927 Filing: 000121390025037618 Input fundies:OperatingCashFlow: -6247000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1319259 Filing: 000121390025037618
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-76.5%

Prior period

USD 51,000

2023-01-01 – 2023-12-31
Current period

USD 12,000

2024-01-01 – 2024-12-31

Exact inputs and evidence

12000 − 51000 = -39000 USD

51000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
12000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Medigus Ltd. · 2024-12-31 Medigus Ltd. (edgar:1618500) Year-over-year change in Capital expenditure: -39000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 12000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1321262 Filing: 000121390025037618 Input fundies:CapitalExpenditure: 51000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1321610 Filing: 000121390025037618
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2024-01-01 – 2024-12-31

Revenue USD 29.86 million 100% of revenue
Operating costs Derived USD 37.88 million 127% of revenue
Operating income −USD 8.02 million −27% of revenue
Tax, interest and other Derived −USD 1.99 million −6.7% of revenue
Net income −USD 6.03 million −20% of revenue

Cash

Operating cash flow −USD 1.82 million −6.1% of revenue
Capital expenditure USD 12,000 0% of revenue
Free cash flow Derived −USD 1.84 million −6.1% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 Not shown: operating income or net income is not reported.
2016 Not shown: operating income or net income is not reported.
2017 Operating loss: operating costs were 1,408% of revenue.
2018 Operating loss: operating costs were 1,630% of revenue.
2019 Operating loss: operating costs were 5,382% of revenue.
2020 Operating loss: operating costs were 1,491% of revenue.
2021 Operating loss: operating costs were 198% of revenue.
2022 Operating loss: operating costs were 115% of revenue.
2023 Operating loss: operating costs were 125% of revenue.
2024 Operating loss: operating costs were 127% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	624000	10180000 Derived	-9556000	Unavailable	Unavailable	-7065000 Derived	Source 2015-01-01 – 2015-12-31: 624000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -9556000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -6981000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 84000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	549000	9640000 Derived	-9091000	Unavailable	Unavailable	-9297000 Derived	Source 2016-01-01 – 2016-12-31: 549000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -9091000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -9265000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 32000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	467000	6575000 Derived	-6108000	-3563000 Derived	-2545000	-4690000 Derived	Source 2017-01-01 – 2017-12-31: 467000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -6108000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -2545000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -4681000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 9000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	436000	7108000 Derived	-6672000	-74000 Derived	-6598000	-4233000 Derived	Source 2018-01-01 – 2018-12-31: 436000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -6672000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -6598000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -4222000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 11000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	273000	14693000 Derived	-14420000	-242000 Derived	-14178000	-2757000 Derived	Source 2019-01-01 – 2019-12-31: 273000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -14420000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -14178000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -2695000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 62000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	531000	7915000 Derived	-7384000	-534000 Derived	-6850000	-6467000 Derived	Source 2020-01-01 – 2020-12-31: 531000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -7384000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -6850000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -6143000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 324000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	10118000	20013000 Derived	-9895000	-13941000 Derived	4046000	-5391000 Derived	Source 2021-01-01 – 2021-12-31: 10118000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -9895000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 4046000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -5250000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 141000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	91858000	105642000 Derived	-13784000	-3969000 Derived	-9815000	-5730000 Derived	Source 2022-01-01 – 2022-12-31: 91858000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -13784000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -9815000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -5656000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 74000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	91724000	115045000 Derived	-23321000	-7296000 Derived	-16025000	-6298000 Derived	Source 2023-01-01 – 2023-12-31: 91724000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -23321000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -16025000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -6247000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 51000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	29858000	37875000 Derived	-8017000	-1990000 Derived	-6027000	-1836000 Derived	Source 2024-01-01 – 2024-12-31: 29858000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -8017000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -6027000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -1824000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 12000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 29.9M 2024

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	624000	Revenue: 624000 Open source
20162016-12-31	Revenue	549000	Revenue: 549000 Open source
20172017-12-31	Revenue	467000	Revenue: 467000 Open source
20182018-12-31	Revenue	436000	Revenue: 436000 Open source
20192019-12-31	Revenue	273000	Revenue: 273000 Open source
20202020-12-31	Revenue	531000	Revenue: 531000 Open source
20212021-12-31	Revenue	10118000	Revenue: 10118000 Open source
20222022-12-31	Revenue	91858000	Revenue: 91858000 Open source
20232023-12-31	Revenue	91724000	Revenue: 91724000 Open source
20242024-12-31	Revenue	29858000	Revenue: 29858000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-67.4% 2024

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 624000 Open source
20162016-12-31	Year over year	-12%	Revenue: 549000 Open source Revenue: 624000 Open source
20172017-12-31	Year over year	-14.9%	Revenue: 467000 Open source Revenue: 549000 Open source
20182018-12-31	Year over year	-6.6%	Revenue: 436000 Open source Revenue: 467000 Open source
20192019-12-31	Year over year	-37.4%	Revenue: 273000 Open source Revenue: 436000 Open source
20202020-12-31	Year over year	94.5%	Revenue: 531000 Open source Revenue: 273000 Open source
20212021-12-31	Year over year	1,805.5%	Revenue: 10118000 Open source Revenue: 531000 Open source
20222022-12-31	Year over year	807.9%	Revenue: 91858000 Open source Revenue: 10118000 Open source
20232023-12-31	Year over year	-0.1%	Revenue: 91724000 Open source Revenue: 91858000 Open source
20242024-12-31	Year over year	-67.4%	Revenue: 29858000 Open source Revenue: 91724000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -26.9% 2024

Net margin -20.2% 2024

Free cash flow margin -6.1% 2024

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	-1,531.4%	Operating Income: -9556000 Open source Revenue: 624000 Open source
20162016-12-31	Operating margin	-1,655.9%	Operating Income: -9091000 Open source Revenue: 549000 Open source
20172017-12-31	Operating margin	-1,307.9%	Operating Income: -6108000 Open source Revenue: 467000 Open source
20182018-12-31	Operating margin	-1,530.3%	Operating Income: -6672000 Open source Revenue: 436000 Open source
20192019-12-31	Operating margin	-5,282.1%	Operating Income: -14420000 Open source Revenue: 273000 Open source
20202020-12-31	Operating margin	-1,390.6%	Operating Income: -7384000 Open source Revenue: 531000 Open source
20212021-12-31	Operating margin	-97.8%	Operating Income: -9895000 Open source Revenue: 10118000 Open source
20222022-12-31	Operating margin	-15%	Operating Income: -13784000 Open source Revenue: 91858000 Open source
20232023-12-31	Operating margin	-25.4%	Operating Income: -23321000 Open source Revenue: 91724000 Open source
20242024-12-31	Operating margin	-26.9%	Operating Income: -8017000 Open source Revenue: 29858000 Open source
2015-12-31	Net margin	Not reported	Revenue: 624000 Open source
2016-12-31	Net margin	Not reported	Revenue: 549000 Open source
20172017-12-31	Net margin	-545%	Net Income: -2545000 Open source Revenue: 467000 Open source
20182018-12-31	Net margin	-1,513.3%	Net Income: -6598000 Open source Revenue: 436000 Open source
20192019-12-31	Net margin	-5,193.4%	Net Income: -14178000 Open source Revenue: 273000 Open source
20202020-12-31	Net margin	-1,290%	Net Income: -6850000 Open source Revenue: 531000 Open source
20212021-12-31	Net margin	40%	Net Income: 4046000 Open source Revenue: 10118000 Open source
20222022-12-31	Net margin	-10.7%	Net Income: -9815000 Open source Revenue: 91858000 Open source
20232023-12-31	Net margin	-17.5%	Net Income: -16025000 Open source Revenue: 91724000 Open source
20242024-12-31	Net margin	-20.2%	Net Income: -6027000 Open source Revenue: 29858000 Open source
20152015-12-31	Free cash flow margin	-1,132.2%	Revenue: 624000 Open source Operating Cash Flow: -6981000 Open source Capital Expenditure: 84000 Open source
20162016-12-31	Free cash flow margin	-1,693.4%	Revenue: 549000 Open source Operating Cash Flow: -9265000 Open source Capital Expenditure: 32000 Open source
20172017-12-31	Free cash flow margin	-1,004.3%	Revenue: 467000 Open source Operating Cash Flow: -4681000 Open source Capital Expenditure: 9000 Open source
20182018-12-31	Free cash flow margin	-970.9%	Revenue: 436000 Open source Operating Cash Flow: -4222000 Open source Capital Expenditure: 11000 Open source
20192019-12-31	Free cash flow margin	-1,009.9%	Revenue: 273000 Open source Operating Cash Flow: -2695000 Open source Capital Expenditure: 62000 Open source
20202020-12-31	Free cash flow margin	-1,217.9%	Revenue: 531000 Open source Operating Cash Flow: -6143000 Open source Capital Expenditure: 324000 Open source
20212021-12-31	Free cash flow margin	-53.3%	Revenue: 10118000 Open source Operating Cash Flow: -5250000 Open source Capital Expenditure: 141000 Open source
20222022-12-31	Free cash flow margin	-6.2%	Revenue: 91858000 Open source Operating Cash Flow: -5656000 Open source Capital Expenditure: 74000 Open source
20232023-12-31	Free cash flow margin	-6.9%	Revenue: 91724000 Open source Operating Cash Flow: -6247000 Open source Capital Expenditure: 51000 Open source
20242024-12-31	Free cash flow margin	-6.1%	Revenue: 29858000 Open source Operating Cash Flow: -1824000 Open source Capital Expenditure: 12000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.8M 2024

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	-6981000	Operating Cash Flow: -6981000 Open source
20162016-12-31	Operating cash flow	-9265000	Operating Cash Flow: -9265000 Open source
20172017-12-31	Operating cash flow	-4681000	Operating Cash Flow: -4681000 Open source
20182018-12-31	Operating cash flow	-4222000	Operating Cash Flow: -4222000 Open source
20192019-12-31	Operating cash flow	-2695000	Operating Cash Flow: -2695000 Open source
20202020-12-31	Operating cash flow	-6143000	Operating Cash Flow: -6143000 Open source
20212021-12-31	Operating cash flow	-5250000	Operating Cash Flow: -5250000 Open source
20222022-12-31	Operating cash flow	-5656000	Operating Cash Flow: -5656000 Open source
20232023-12-31	Operating cash flow	-6247000	Operating Cash Flow: -6247000 Open source
20242024-12-31	Operating cash flow	-1824000	Operating Cash Flow: -1824000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.8M 2024

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	-7065000	Operating Cash Flow: -6981000 Open source Capital Expenditure: 84000 Open source
20162016-12-31	Free cash flow	-9297000	Operating Cash Flow: -9265000 Open source Capital Expenditure: 32000 Open source
20172017-12-31	Free cash flow	-4690000	Operating Cash Flow: -4681000 Open source Capital Expenditure: 9000 Open source
20182018-12-31	Free cash flow	-4233000	Operating Cash Flow: -4222000 Open source Capital Expenditure: 11000 Open source
20192019-12-31	Free cash flow	-2757000	Operating Cash Flow: -2695000 Open source Capital Expenditure: 62000 Open source
20202020-12-31	Free cash flow	-6467000	Operating Cash Flow: -6143000 Open source Capital Expenditure: 324000 Open source
20212021-12-31	Free cash flow	-5391000	Operating Cash Flow: -5250000 Open source Capital Expenditure: 141000 Open source
20222022-12-31	Free cash flow	-5730000	Operating Cash Flow: -5656000 Open source Capital Expenditure: 74000 Open source
20232023-12-31	Free cash flow	-6298000	Operating Cash Flow: -6247000 Open source Capital Expenditure: 51000 Open source
20242024-12-31	Free cash flow	-1836000	Operating Cash Flow: -1824000 Open source Capital Expenditure: 12000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

53.2% 2024

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Liabilities / assets	Not reported	No source recorded
20162016-12-31	Liabilities / assets	38%	Total Liabilities: 1797000 Open source Total Assets: 4724000 Open source
20172017-12-31	Liabilities / assets	23.6%	Total Liabilities: 1699000 Open source Total Assets: 7210000 Open source
20182018-12-31	Liabilities / assets	28.1%	Total Liabilities: 3160000 Open source Total Assets: 11239000 Open source
20192019-12-31	Liabilities / assets	39%	Total Liabilities: 5203000 Open source Total Assets: 13334000 Open source
20202020-12-31	Liabilities / assets	19%	Total Liabilities: 6141000 Open source Total Assets: 32335000 Open source
20212021-12-31	Liabilities / assets	13.9%	Total Liabilities: 8297000 Open source Total Assets: 59730000 Open source
20222022-12-31	Liabilities / assets	44%	Total Liabilities: 42962000 Open source Total Assets: 97651000 Open source
20232023-12-31	Liabilities / assets	49.2%	Total Liabilities: 31461000 Open source Total Assets: 63896000 Open source
20242024-12-31	Liabilities / assets	53.2%	Total Liabilities: 19960000 Open source Total Assets: 37549000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.14× 2024

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Current assets / current liabilities	Not reported	No source recorded
20162016-12-31	Current assets / current liabilities	2.69×	Current Assets: 3586000 Open source Current Liabilities: 1334000 Open source
20172017-12-31	Current assets / current liabilities	4.49×	Current Assets: 6814000 Open source Current Liabilities: 1516000 Open source
20182018-12-31	Current assets / current liabilities	3.76×	Current Assets: 11134000 Open source Current Liabilities: 2963000 Open source
20192019-12-31	Current assets / current liabilities	2.46×	Current Assets: 8279000 Open source Current Liabilities: 3365000 Open source
20202020-12-31	Current assets / current liabilities	6.84×	Current Assets: 24045000 Open source Current Liabilities: 3514000 Open source
20212021-12-31	Current assets / current liabilities	4.77×	Current Assets: 31654000 Open source Current Liabilities: 6639000 Open source
20222022-12-31	Current assets / current liabilities	1.39×	Current Assets: 52258000 Open source Current Liabilities: 37627000 Open source
20232023-12-31	Current assets / current liabilities	1.08×	Current Assets: 31671000 Open source Current Liabilities: 29268000 Open source
20242024-12-31	Current assets / current liabilities	1.14×	Current Assets: 20984000 Open source Current Liabilities: 18423000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	Unavailable Not reported for this period.	−USD 6.98 million Exact value Exact value: -6981000 USD 2015-01-01 – 2015-12-31: -6981000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Medigus Ltd. · 2015-12-31 Medigus Ltd. (edgar:1618500) Operating Cash Flow: -6981000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6981000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390018003304/mdgs-20171231.xml#162172 Filing: 000121390018003304 The citation records this snapshot. The page link may show a newer release later.	USD 84,000 Exact value Exact value: 84000 USD 2015-01-01 – 2015-12-31: 84000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Medigus Ltd. · 2015-12-31 Medigus Ltd. (edgar:1618500) Capital Expenditure: 84000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 84000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390018003304/mdgs-20171231.xml#162796 Filing: 000121390018003304 The citation records this snapshot. The page link may show a newer release later.	−USD 7.07 million Calculation and evidence -6981000 − 84000 USD Exact free cash flow: -7065000 USD 2015-01-01 – 2015-12-31: -6981000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 84000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Medigus Ltd. · 2015-12-31 Medigus Ltd. (edgar:1618500) Free cash flow: -7065000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6981000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390018003304/mdgs-20171231.xml#162172 Filing: 000121390018003304 Input fundies:CapitalExpenditure: 84000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390018003304/mdgs-20171231.xml#162796 Filing: 000121390018003304 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	Unavailable Not reported for this period.	−USD 9.27 million Exact value Exact value: -9265000 USD 2016-01-01 – 2016-12-31: -9265000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Medigus Ltd. · 2016-12-31 Medigus Ltd. (edgar:1618500) Operating Cash Flow: -9265000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9265000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390019005099/mdgs-20181231.xml#168034 Filing: 000121390019005099 The citation records this snapshot. The page link may show a newer release later.	USD 32,000 Exact value Exact value: 32000 USD 2016-01-01 – 2016-12-31: 32000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Medigus Ltd. · 2016-12-31 Medigus Ltd. (edgar:1618500) Capital Expenditure: 32000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 32000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390019005099/mdgs-20181231.xml#168722 Filing: 000121390019005099 The citation records this snapshot. The page link may show a newer release later.	−USD 9.3 million Calculation and evidence -9265000 − 32000 USD Exact free cash flow: -9297000 USD 2016-01-01 – 2016-12-31: -9265000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 32000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Medigus Ltd. · 2016-12-31 Medigus Ltd. (edgar:1618500) Free cash flow: -9297000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9265000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390019005099/mdgs-20181231.xml#168034 Filing: 000121390019005099 Input fundies:CapitalExpenditure: 32000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390019005099/mdgs-20181231.xml#168722 Filing: 000121390019005099 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 2.55 million Exact value Exact value: -2545000 USD 2017-01-01 – 2017-12-31: -2545000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Medigus Ltd. · 2017-12-31 Medigus Ltd. (edgar:1618500) Net Income: -2545000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2545000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390020009750/mdgs-20191231.xml#195424 Filing: 000121390020009750 The citation records this snapshot. The page link may show a newer release later.	−USD 4.68 million Exact value Exact value: -4681000 USD 2017-01-01 – 2017-12-31: -4681000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Medigus Ltd. · 2017-12-31 Medigus Ltd. (edgar:1618500) Operating Cash Flow: -4681000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4681000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390020009750/mdgs-20191231.xml#220214 Filing: 000121390020009750 The citation records this snapshot. The page link may show a newer release later.	USD 9,000 Exact value Exact value: 9000 USD 2017-01-01 – 2017-12-31: 9000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Medigus Ltd. · 2017-12-31 Medigus Ltd. (edgar:1618500) Capital Expenditure: 9000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390020009750/mdgs-20191231.xml#220860 Filing: 000121390020009750 The citation records this snapshot. The page link may show a newer release later.	−USD 4.69 million Calculation and evidence -4681000 − 9000 USD Exact free cash flow: -4690000 USD 2017-01-01 – 2017-12-31: -4681000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 9000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Medigus Ltd. · 2017-12-31 Medigus Ltd. (edgar:1618500) Free cash flow: -4690000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4681000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390020009750/mdgs-20191231.xml#220214 Filing: 000121390020009750 Input fundies:CapitalExpenditure: 9000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390020009750/mdgs-20191231.xml#220860 Filing: 000121390020009750 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 6.6 million Exact value Exact value: -6598000 USD 2018-01-01 – 2018-12-31: -6598000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Medigus Ltd. · 2018-12-31 Medigus Ltd. (edgar:1618500) Net Income: -6598000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6598000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390021026459/mdgs-20201231.xml#278474 Filing: 000121390021026459 The citation records this snapshot. The page link may show a newer release later.	−USD 4.22 million Exact value Exact value: -4222000 USD 2018-01-01 – 2018-12-31: -4222000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Medigus Ltd. · 2018-12-31 Medigus Ltd. (edgar:1618500) Operating Cash Flow: -4222000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4222000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390021026459/mdgs-20201231.xml#311220 Filing: 000121390021026459 The citation records this snapshot. The page link may show a newer release later.	USD 11,000 Exact value Exact value: 11000 USD 2018-01-01 – 2018-12-31: 11000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Medigus Ltd. · 2018-12-31 Medigus Ltd. (edgar:1618500) Capital Expenditure: 11000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390021026459/mdgs-20201231.xml#311867 Filing: 000121390021026459 The citation records this snapshot. The page link may show a newer release later.	−USD 4.23 million Calculation and evidence -4222000 − 11000 USD Exact free cash flow: -4233000 USD 2018-01-01 – 2018-12-31: -4222000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 11000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Medigus Ltd. · 2018-12-31 Medigus Ltd. (edgar:1618500) Free cash flow: -4233000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4222000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390021026459/mdgs-20201231.xml#311220 Filing: 000121390021026459 Input fundies:CapitalExpenditure: 11000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390021026459/mdgs-20201231.xml#311867 Filing: 000121390021026459 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 14.18 million Exact value Exact value: -14178000 USD 2019-01-01 – 2019-12-31: -14178000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Medigus Ltd. · 2019-12-31 Medigus Ltd. (edgar:1618500) Net Income: -14178000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14178000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390022022705/f20f2021_medigusltd.htm#1175831 Filing: 000121390022022705 The citation records this snapshot. The page link may show a newer release later.	−USD 2.7 million Exact value Exact value: -2695000 USD 2019-01-01 – 2019-12-31: -2695000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Medigus Ltd. · 2019-12-31 Medigus Ltd. (edgar:1618500) Operating Cash Flow: -2695000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2695000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390022022705/f20f2021_medigusltd.htm#1355024 Filing: 000121390022022705 The citation records this snapshot. The page link may show a newer release later.	USD 62,000 Exact value Exact value: 62000 USD 2019-01-01 – 2019-12-31: 62000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Medigus Ltd. · 2019-12-31 Medigus Ltd. (edgar:1618500) Capital Expenditure: 62000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 62000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390022022705/f20f2021_medigusltd.htm#1357386 Filing: 000121390022022705 The citation records this snapshot. The page link may show a newer release later.	−USD 2.76 million Calculation and evidence -2695000 − 62000 USD Exact free cash flow: -2757000 USD 2019-01-01 – 2019-12-31: -2695000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 62000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Medigus Ltd. · 2019-12-31 Medigus Ltd. (edgar:1618500) Free cash flow: -2757000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2695000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390022022705/f20f2021_medigusltd.htm#1355024 Filing: 000121390022022705 Input fundies:CapitalExpenditure: 62000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390022022705/f20f2021_medigusltd.htm#1357386 Filing: 000121390022022705 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 6.85 million Exact value Exact value: -6850000 USD 2020-01-01 – 2020-12-31: -6850000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Medigus Ltd. · 2020-12-31 Medigus Ltd. (edgar:1618500) Net Income: -6850000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6850000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390023036036/f20f2022_medigusltd.htm#1299561 Filing: 000121390023036036 The citation records this snapshot. The page link may show a newer release later.	−USD 6.14 million Exact value Exact value: -6143000 USD 2020-01-01 – 2020-12-31: -6143000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Medigus Ltd. · 2020-12-31 Medigus Ltd. (edgar:1618500) Operating Cash Flow: -6143000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6143000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390023036036/f20f2022_medigusltd.htm#1563530 Filing: 000121390023036036 The citation records this snapshot. The page link may show a newer release later.	USD 324,000 Exact value Exact value: 324000 USD 2020-01-01 – 2020-12-31: 324000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Medigus Ltd. · 2020-12-31 Medigus Ltd. (edgar:1618500) Capital Expenditure: 324000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 324000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390023036036/f20f2022_medigusltd.htm#1565793 Filing: 000121390023036036 The citation records this snapshot. The page link may show a newer release later.	−USD 6.47 million Calculation and evidence -6143000 − 324000 USD Exact free cash flow: -6467000 USD 2020-01-01 – 2020-12-31: -6143000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 324000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Medigus Ltd. · 2020-12-31 Medigus Ltd. (edgar:1618500) Free cash flow: -6467000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6143000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390023036036/f20f2022_medigusltd.htm#1563530 Filing: 000121390023036036 Input fundies:CapitalExpenditure: 324000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390023036036/f20f2022_medigusltd.htm#1565793 Filing: 000121390023036036 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	USD 4.05 million Exact value Exact value: 4046000 USD 2021-01-01 – 2021-12-31: 4046000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Medigus Ltd. · 2021-12-31 Medigus Ltd. (edgar:1618500) Net Income: 4046000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 4046000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390024034901/ea0203783-20f_xylotech.htm#1148973 Filing: 000121390024034901 The citation records this snapshot. The page link may show a newer release later.	−USD 5.25 million Exact value Exact value: -5250000 USD 2021-01-01 – 2021-12-31: -5250000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Medigus Ltd. · 2021-12-31 Medigus Ltd. (edgar:1618500) Operating Cash Flow: -5250000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5250000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390024034901/ea0203783-20f_xylotech.htm#1450504 Filing: 000121390024034901 The citation records this snapshot. The page link may show a newer release later.	USD 141,000 Exact value Exact value: 141000 USD 2021-01-01 – 2021-12-31: 141000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Medigus Ltd. · 2021-12-31 Medigus Ltd. (edgar:1618500) Capital Expenditure: 141000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 141000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390024034901/ea0203783-20f_xylotech.htm#1452788 Filing: 000121390024034901 The citation records this snapshot. The page link may show a newer release later.	−USD 5.39 million Calculation and evidence -5250000 − 141000 USD Exact free cash flow: -5391000 USD 2021-01-01 – 2021-12-31: -5250000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 141000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Medigus Ltd. · 2021-12-31 Medigus Ltd. (edgar:1618500) Free cash flow: -5391000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5250000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390024034901/ea0203783-20f_xylotech.htm#1450504 Filing: 000121390024034901 Input fundies:CapitalExpenditure: 141000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390024034901/ea0203783-20f_xylotech.htm#1452788 Filing: 000121390024034901 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 9.82 million Exact value Exact value: -9815000 USD 2022-01-01 – 2022-12-31: -9815000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Medigus Ltd. · 2022-12-31 Medigus Ltd. (edgar:1618500) Net Income: -9815000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9815000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1090058 Filing: 000121390025037618 The citation records this snapshot. The page link may show a newer release later.	−USD 5.66 million Exact value Exact value: -5656000 USD 2022-01-01 – 2022-12-31: -5656000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Medigus Ltd. · 2022-12-31 Medigus Ltd. (edgar:1618500) Operating Cash Flow: -5656000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5656000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1319592 Filing: 000121390025037618 The citation records this snapshot. The page link may show a newer release later.	USD 74,000 Exact value Exact value: 74000 USD 2022-01-01 – 2022-12-31: 74000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Medigus Ltd. · 2022-12-31 Medigus Ltd. (edgar:1618500) Capital Expenditure: 74000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 74000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1321959 Filing: 000121390025037618 The citation records this snapshot. The page link may show a newer release later.	−USD 5.73 million Calculation and evidence -5656000 − 74000 USD Exact free cash flow: -5730000 USD 2022-01-01 – 2022-12-31: -5656000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 74000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Medigus Ltd. · 2022-12-31 Medigus Ltd. (edgar:1618500) Free cash flow: -5730000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5656000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1319592 Filing: 000121390025037618 Input fundies:CapitalExpenditure: 74000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1321959 Filing: 000121390025037618 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 16.03 million Exact value Exact value: -16025000 USD 2023-01-01 – 2023-12-31: -16025000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Medigus Ltd. · 2023-12-31 Medigus Ltd. (edgar:1618500) Net Income: -16025000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16025000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1089724 Filing: 000121390025037618 The citation records this snapshot. The page link may show a newer release later.	−USD 6.25 million Exact value Exact value: -6247000 USD 2023-01-01 – 2023-12-31: -6247000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Medigus Ltd. · 2023-12-31 Medigus Ltd. (edgar:1618500) Operating Cash Flow: -6247000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6247000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1319259 Filing: 000121390025037618 The citation records this snapshot. The page link may show a newer release later.	USD 51,000 Exact value Exact value: 51000 USD 2023-01-01 – 2023-12-31: 51000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Medigus Ltd. · 2023-12-31 Medigus Ltd. (edgar:1618500) Capital Expenditure: 51000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 51000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1321610 Filing: 000121390025037618 The citation records this snapshot. The page link may show a newer release later.	−USD 6.3 million Calculation and evidence -6247000 − 51000 USD Exact free cash flow: -6298000 USD 2023-01-01 – 2023-12-31: -6247000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 51000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Medigus Ltd. · 2023-12-31 Medigus Ltd. (edgar:1618500) Free cash flow: -6298000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6247000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1319259 Filing: 000121390025037618 Input fundies:CapitalExpenditure: 51000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1321610 Filing: 000121390025037618 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 6.03 million Exact value Exact value: -6027000 USD 2024-01-01 – 2024-12-31: -6027000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Medigus Ltd. · 2024-12-31 Medigus Ltd. (edgar:1618500) Net Income: -6027000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6027000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1089392 Filing: 000121390025037618 The citation records this snapshot. The page link may show a newer release later.	−USD 1.82 million Exact value Exact value: -1824000 USD 2024-01-01 – 2024-12-31: -1824000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Medigus Ltd. · 2024-12-31 Medigus Ltd. (edgar:1618500) Operating Cash Flow: -1824000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1824000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1318927 Filing: 000121390025037618 The citation records this snapshot. The page link may show a newer release later.	USD 12,000 Exact value Exact value: 12000 USD 2024-01-01 – 2024-12-31: 12000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Medigus Ltd. · 2024-12-31 Medigus Ltd. (edgar:1618500) Capital Expenditure: 12000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1321262 Filing: 000121390025037618 The citation records this snapshot. The page link may show a newer release later.	−USD 1.84 million Calculation and evidence -1824000 − 12000 USD Exact free cash flow: -1836000 USD 2024-01-01 – 2024-12-31: -1824000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 12000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Medigus Ltd. · 2024-12-31 Medigus Ltd. (edgar:1618500) Free cash flow: -1836000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1618500?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1824000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1318927 Filing: 000121390025037618 Input fundies:CapitalExpenditure: 12000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1618500/000121390025037618/ea0238675-20f_xylotech.htm#1321262 Filing: 000121390025037618 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

443 filings · 1,332 latest values · 1,332 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001618500, 1618500, MDGS, MDGSW, XYLO, edgar:1618500

Also known as MEDIGUS LTD., Medigus Ltd., XYLO TECHNOLOGIES LTD, Xylo Technologies Ltd.

Medigus Ltd.

Latest quarter

Revenue

Operating margin

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2024 2024-01-01 – 2024-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation